FDA approves most expensive medicine ever, priced at $2M per treatment

FDA approves most expensive medicine ever, priced at $2M per treatment

U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys a baby’s muscle control and kills nearly all of thos

Boeing CEO to face questions on 737 MAX crashes from U.S. lawmakers
737 Max expected to resume commercial service in January: Boeing
Widespread Target cash register outage causes long lines, exasperated shoppers

U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys a baby’s muscle control and kills nearly all of those with the most common type of the disease within a couple of years.READ MORE: FDA approves drug to make cow poo less smellyThe treatment is priced at $2.125 million. Out-of-pocket costs for patients will vary based on insurance coverage.The medicine, sold by the Swiss drugmaker Novartis, is a gene therapy that treats an inherited condition called spinal muscular atrophy. The treatment targets a defective gene that weakens a child’s muscles so dramatically that they become unable to move, and eventually unable to swallow or breathe. It strikes about 400 babies born in the U.S. each year.The Food and Drug Administration on Friday approved the treatment, called Zolgensma, for all children under age two who are confirmed by a genetic test to have any of the four types of the disease. The therapy is a one-time infusion that takes about an hour.WATCH: FDA approves new cancer-treating drug

COMMENTS

WORDPRESS: 0
DISQUS: 0